Navigation Links
Scientists devise targeted therapy strategy for rare form of childhood cancer
Date:3/29/2011

BOSTON--By "distracting" cancer proteins from their usual activity, scientists at Dana-Farber Cancer Institute and Brigham and Women's Hospital have caused cells in a rare, lethal form of cancer to begin behaving like normal cells -- one of the longest-standing, and most rarely achieved, goals of cancer research. The study's findings are published online by the journal Cancer Research and will appear later in a print issue.

When the approach was tested in a child with an advanced case of the malignancy, known as NUT midline carcinoma (NMC), it slowed the course of the disease for several months. That result, in a cancer for which there are no other effective treatments, is a powerful impetus for making the new therapy available to patients in clinical trials, the authors assert.

"NUT midline carcinoma arises people of all ages, but predominantly in children and young adults," explained the study's senior co-author, James Bradner, MD, of Dana-Farber. "It usually originates in the chest, sometimes in the head or neck, and is often mistaken for other types of cancer. Traditional therapy involves surgery, radiation, and chemotherapy, but even in combination these approaches don't work well: most patients live only about nine and a half months after diagnosis. As we've learned more about the molecular basis of the disease, we've begun to be able to devise therapies against it."

The cause of the disease was discovered by Christopher French, MD, a senior author of the study from Brigham and Women's Hospital. It results from a "translocation" in which two genes from different chromosomes stick together and give rise to an abnormal, fused protein called BRD4-NUT. While Bradner and his colleagues have subsequently developed and studied compounds that target BRD4-NUT directly, the newly published study involves a more oblique approach.

Researchers discovered that BRD4-NUT causes cells to become cancerous by attaching to DNA's
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
5. Scientists find donut-shaped structure of enzyme involved in energy metabolism
6. Neuroscientists reveal new links that regulate brain electrical activity
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. Scientists Spot Genetic Fingerprints of Individual Cancers
10. Scientists Unravel Mysteries of Intelligence
11. MSU scientists develop more effective method of predicting lead-poisoning risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists devise targeted therapy strategy for rare form of childhood cancer
(Date:5/20/2013)... The automated external defibrillator market ... categories - semi-automated and fully automated defibrillators. Based ... categories, namely, hospitals, pre-hospital, public access, alternate care, ... Automated external defibrillators play an important role in ... Considering the life-saving potential of AEDs, legislations requiring ...
(Date:5/20/2013)... Recent environmental concerns have helped ... and sustainable inputs in packaging products. As such, ... promote the use of sustainable materials, thereby driving ... industry . “Tax subsidies and operating cost savings ... analyst Deonta Smith. “For example, many packaging product ...
(Date:5/20/2013)... In order to prepare for the long hot ... DrSmartphoneMD launched an article series to raise awareness about skincare ... launched with the precautions that need to be taken ... are not one of the 3.5 million cases of skin ... of all skin cancer cases are associated with exposure to ...
(Date:5/20/2013)... Parker Waichman LLP, a national law firm ... defective drugs, has filed a lawsuit on behalf of ... the diabetes drug medication Actos (pioglitazone) caused bladder ... 2013, in the U.S. District Court for the Western ... one of thousands of cases pending in the Actos ...
(Date:5/20/2013)... 20, 2013 Mirena IUD lawsuit ... multidistrict litigation recently established in U.S. District Court, Southern ... According to court records, the litigation’s first Status Conference ... to Plaintiff’s leadership positions were discussed. So far, ... Southern District of New York, all of which allege ...
Breaking Medicine News(10 mins):Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Combat Skin Cancer In Summer Months 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3
... Security Disability Insurance recipients; time-intensive process of receiving benefits can include ... ... Belleville, Ill. (Vocus) June 25, 2008 -- The number ... benefits continued to grow in 2007. This means more people are ...
... of patients admitted to the hospital have alcohol/drug abuse ... sharply in recent years, according to a study in ... Abuse Treatment (JSAT). , "Our results demonstrated ... and the striking financial costs placed on the hospital, ...
... Richer countries perform most, but safety an issue in ... News) -- About 234 million major surgeries are performed ... in high-income countries than in low-income countries, U.S. researchers ... of Public Health, and his colleagues defined major surgeries ...
... TALLAHASSEE, Fla., June 25 Pharmavite, ... has chosen the on-line consumer-centric,program, LearnSomethingAbout(TM), ... Inc. created the engaging, consumer-oriented multimedia,program ... of national retailers., "LearnSomething shares ...
... Mass., June 25 Cynosure, Inc.,(Nasdaq: CYNO ), ... of,light-based aesthetic treatment systems, today announced the opening of ... Located in the Chao,Yang District of Beijing, the office ... sales and marketing for Cynosure China, the company,s,wholly owned ...
... LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider ... brand, is providing an update on the ... for the company,s services., "Macro-economic conditions ... spending, leading to continued softness in,LasikPlus(R) appointments ...
Cached Medicine News:Health News:SSDI Recipients Ask: When Do I Get My Benefits? 2Health News:SSDI Recipients Ask: When Do I Get My Benefits? 3Health News:Study shows high rates, rising costs of alcohol/drug disorders in hospitalized patients 2Health News:Worldwide Surgery Rates Tied to Economic Status 2Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Cynosure Expands Presence in China with the Opening of Sales Office in Beijing 2Health News:LCA-Vision Provides Business Update and Market Review 2Health News:LCA-Vision Provides Business Update and Market Review 3Health News:LCA-Vision Provides Business Update and Market Review 4
(Date:5/20/2013)... , May 20, 2013   Life Technologies Corporation ... its Applied Biosystems™ 3500 Dx and 3500xL Dx Genetic ... Protection against Health Risks in Mexico ... extension of Life Technologies, capabilities to serve the clinical ... with Sanger -based solutions.  ...
(Date:5/20/2013)... -- TNI BioTech, Inc. (OTCQB: TNIB), a biotech company combating ... body,s immune system using patented immunotherapy, announced its common stock ... the ticker symbol "TNIB" commencing May 17, 2013. Investors will ... quotes for TNIB at http://www.otcmarkets.com/stock/TNIB/quote . ... BioTech, Inc. stated, "We are very pleased to provide ...
(Date:5/20/2013)... 20, 2013 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that surveyed U.S. ... greater effect on quality of life is among ... high level of subjectivity and variability of tests ... leaders state that it is difficult to differentiate ...
Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2
... tips eliminate false signals and contamination ... tested, Promega Barrier Tips offer performance ... nucleic acids (PCR(a)), radioactive isotopes, tissue ... serological specimens. , Promega Barrier Tips ...
... Finntip Filters are ideal ... amplification methods, or for ... contamination might occur. They ... DNA/RNA solutions, infectious materials, ...
1000 L, Racked, Filtered, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes....
Inquire...
Medicine Products: